Escitalopram population pharmacokinetics in people living with HIV and in the psychiatric population: drug-drug interactions and probability of target attainment

HIV / AIDS

Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV

doi: 10.1093/ofid/ofz531.

HIV / AIDS

Prevalence of potential drug-drug interactions in patients of the Swiss HIV Cohort Study in the era of HIV integrase inhibitors

Clin Infect Dis.

Deutschmann E, Bucher HC, Jaeckel S, Gibbons S, McAllister K, Scherrer AU, Braun DL, Cavassini M, Hachfeld A, Calmy A, Battegay M, Cipriani M, Elzi L, Young J, Lopez-Centeno B, Berenguer J, Khoo S, Moffa G, Marzolini C, Swiss HIV Cohort Study.

doi: 10.1093/cid/ciaa918.

HIV / AIDS

Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017

J Int AIDS Soc.

Ruffieux Y, Lemsalu L, Aebi-Popp K, Calmy A, Cavassini M, Fux CA, Günthard HF, Marzolini C, Scherrer A, Vernazza P, Keiser O, Egger M, Swiss HIV Cohort Study and the Swiss National Cohort.

doi: 10.1002/jia2.25339.

HIV / AIDS

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

HIV Med.

Ryom L, Cotter A, De Miguel R, Béguelin C, Podlekareva D, Arribas JR, Marzolini C, Mallon P, Rauch A, Kirk O, Molina JM, Guaraldi G, Winston A, Bhagani S, Cinque P, Kowalska JD, Collins S, Battegay M, EACS Governing Board.

doi: 10.1111/hiv.12878.

HIV / AIDS

Aging does not impact drug-drug interaction magnitudes with antiretrovirals: a Swiss HIV Cohort Study

AIDS.

Stader F, Decosterd L, Stoeckle M, Cavassini M, Battegay M, Saldanha SA, Marzolini C, Courlet P, and the Swiss HIV Cohort Study

doi: 10.1097/QAD.0000000000002489.

SPECIAL REPORT

HIV / AIDS

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

HIV / AIDS

Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence

HIV Med

Punekar YS, Parks D, Joshi M, Kaur S, Evitt L, Chounta V, Radford M, Jha D, Ferrante S, Sharma S, Van Wyk J, de Ruiter A

doi: 10.1111/hiv.13050

Bacterial InfectionsHIV / AIDS

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

Clin Infect Dis.

Campbell JR, Al-Jahdali H, Bah B, Belo M, Cook VJ, Long R, Schwartzman K, Trajman A, Menzies D

doi: 10.1093/cid/ciaa1169.

HIV / AIDS

Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection

HIV Med.

Martin-Iguacel R, Pedersen C, Omland LH, Søndergaard J, Jensen J, Llibre JM, Johansen IS, Obel N, Rasmussen LD

doi: 10.1111/hiv.12735.

Related content

Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV

Prevalence of potential drug-drug interactions in patients of the Swiss HIV Cohort Study in the era of HIV integrase inhibitors

Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

Aging does not impact drug-drug interaction magnitudes with antiretrovirals: a Swiss HIV Cohort Study

11. Konferenz der Internationalen AIDS-Gesellschaft (IAS) 2021

Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection